{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:22:04Z","timestamp":1790767324193,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although HIV-associated pulmonary hypertension and primary pulmonary hypertension (PPH) are clinically and histologically similar, treatment options for the former are limited. Treatment with calcium channel blockers (CCB), proven to be beneficial in a subset of patients with PPH, has been disappointing in HIV-associated pulmonary hypertension and there are no data examining the effects of long-term epoprostenol in this entity. Six patients with severe HIV-associated pulmonary hypertension were treated with continuous intravenous epoprostenol infusions. Acute infusion of epoprostenol resulted in a significant (p &amp;lt; 0.05) decrease in mean pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) of 16.4 and 32.7%, respectively, and a significant (p &amp;lt; 0.05) increase in mean cardiac output (CO) of 36.9%. At 1 yr, mean PAP and PVR had decreased by 21.7 and 54.9% (p &amp;lt; 0.05), respectively, and mean CO had increased by 51.4% (p &amp;lt; 0.05) when compared with baseline values. Repeat catheterizations of three patients at 2 yr and one patient at 40 mo demonstrated further improvement or maintenance of hemodynamics. In addition, NYHA functional class improved in all patients. We conclude that epoprostenol infusion is effective in improving hemodynamic and functional status in this cohort of six patients with HIV-associated pulmonary hypertension acutely and long-term.<\/jats:p>","DOI":"10.1164\/ajrccm.162.5.2004042","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:25:08Z","timestamp":1365085508000},"page":"1846-1850","source":"Crossref","is-referenced-by-count":135,"title":["Epoprostenol (Prostacyclin) Therapy in HIV-associated Pulmonary Hypertension"],"prefix":"10.1093","volume":"162","author":[{"given":"ROBIN V.","family":"AGUILAR","sequence":"first","affiliation":[{"name":"The Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HARRISON W.","family":"FARBER","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,11,1]]},"reference":[{"key":"2026032708341537200_B1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1378\/chest.114.1.337","article-title":"Microvascular cytomegalovirus endothelialitis of the lung: a possible cause of secondary pulmonary hypertension in a patient with AIDS.","volume":"114","author":"Smith","year":"1998","journal-title":"Chest"},{"key":"2026032708341537200_B2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/ajrccm\/145.5.1196","article-title":"Primary pulmonary hypertension in association with human immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive pulmonary arteriopathy.","volume":"145","author":"Mette","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2026032708341537200_B3","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/0002-9149(89)90594-8","article-title":"Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome.","volume":"64","author":"Himelman","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026032708341537200_B4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0002-9343(90)90105-M","article-title":"Primary pulmonary hypertension associated with human immunodeficiency viral infection.","volume":"89","author":"Coplan","year":"1990","journal-title":"Am J Med"},{"key":"2026032708341537200_B5","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.100.5.1268","article-title":"Primary pulmonary hypertension in HIV infection.","volume":"100","author":"Speich","year":"1991","journal-title":"Chest"},{"key":"2026032708341537200_B6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1378\/chest.101.2.474","article-title":"Pulmonary hypertension and human immunodeficiency virus infection: two reports and a review of the literature.","volume":"101","author":"Polos","year":"1992","journal-title":"Chest"},{"key":"2026032708341537200_B7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00007611-199403000-00012","article-title":"HIV and pulmonary hypertension: a review.","volume":"87","author":"Mani","year":"1994","journal-title":"S Med J"},{"key":"2026032708341537200_B8","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.CIR.89.6.2722","article-title":"Pulmonary hypertension in patients human immunodeficiency virus infection: comparison with primary pulmonary hypertension.","volume":"89","author":"Petitpretz","year":"1994","journal-title":"Circulation"},{"key":"2026032708341537200_B9"},{"key":"2026032708341537200_B10","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/ajrccm.155.3.9117037","article-title":"HIV-associated primary pulmonary hypertension: a case control study.","volume":"155","author":"Opravil","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708341537200_B11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0025-6196(11)63616-1","article-title":"Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases.","volume":"73","author":"Mesa","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"2026032708341537200_B12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0735-1097(91)90556-O","article-title":"High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing.","volume":"18","author":"Rich","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"2026032708341537200_B13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"2026032708341537200_B14","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(84)91452-1","article-title":"Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin).","volume":"1","author":"Higgenbottam","year":"1984","journal-title":"Lancet"},{"key":"2026032708341537200_B15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-121-6-199409150-00003","article-title":"Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.","volume":"121","author":"Barst","year":"1994","journal-title":"Ann Intern Med"},{"key":"2026032708341537200_B16","doi-asserted-by":"crossref","first-page":"67A","DOI":"10.1016\/S0002-9149(99)80386-5","article-title":"Role of prostacyclin in the treatment of primary pulmonary hypertension.","volume":"75","author":"Cremona","year":"1995","journal-title":"Am J Cardiol"},{"key":"2026032708341537200_B17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":". A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"2026032708341537200_B18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0735-1097(97)00187-3","article-title":"Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.","volume":"30","author":"Shapiro","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026032708341537200_B19","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.95.6.1479","article-title":"Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension.","volume":"95","author":"Hinderliter","year":"1997","journal-title":"Circulation"},{"key":"2026032708341537200_B20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial.","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"2026032708341537200_B21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N Engl J Med"},{"key":"2026032708341537200_B22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.7326\/0003-4819-127-11-199712010-00030","article-title":"Prostacyclin for HIV-associated pulmonary hypertension [letter].","volume":"127","author":"Stricker","year":"1997","journal-title":"Ann Intern Med"},{"key":"2026032708341537200_B23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":". Primary pulmonary hypertension: a national prospective study.","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"2026032708341537200_B24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/1529-0131(199803)41:3<466::AID-ART13>3.0.CO;2-O","article-title":"The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.","volume":"41","author":"Menon","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2026032708341537200_B25","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.1378\/chest.114.1_Supplement.80S","article-title":"Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin).","volume":"114","author":"Humbert","year":"1998","journal-title":"Chest"},{"key":"2026032708341537200_B26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-130-9-199905040-00014","article-title":"Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series.","volume":"130","author":"McLaughlin","year":"1999","journal-title":"Ann Intern Med"},{"key":"2026032708341537200_B27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007890-199702270-00020","article-title":"Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension.","volume":"63","author":"Kuo","year":"1997","journal-title":"Transplantation"},{"key":"2026032708341537200_B28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00007890-199802270-00001","article-title":"Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.","volume":"65","author":"Plotkin","year":"1998","journal-title":"Transplantation"},{"key":"2026032708341537200_B29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00000542-199901000-00036","article-title":"The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.","volume":"90","author":"Ramsay","year":"1999","journal-title":"Anesthesiology"},{"key":"2026032708341537200_B30","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X","article-title":"Systemic sclerosis-associated pulmonary hypertension: acute and long-term effects of epoprostenol (prostacyclin).","volume":"42","author":"Klings","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2026032708341537200_B31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.117.1.14","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.","volume":"117","author":"Robbins","year":"2000","journal-title":"Chest"},{"key":"2026032708341537200_B32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial.","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/162\/5\/1846\/67543953\/ajrccm_162_5_1846.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/162\/5\/1846\/67543953\/ajrccm_162_5_1846.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:34:26Z","timestamp":1774614866000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/162\/5\/1846\/8541102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,1]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2000,11,1]]},"published-print":{"date-parts":[[2000,11,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.162.5.2004042","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,11]]},"published":{"date-parts":[[2000,11,1]]}}}